Nucleic acid molecules encoding autoactivating type I pancreatic proelastase proteins
AssigneeProteon Therapeutics, Inc.
InventorsF. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
Life of this patent
Estimating the term…
Loading patent…
AssigneeProteon Therapeutics, Inc.
InventorsF. Nicholas Franano, Kimberly Bland, Marco D. Wong, Bee C. Ding
Estimating the term…
The present invention relates to methods for the manufacture, purification, formulation, and use of biologically active recombinant elastase proteins. Described are recombinant methods for producing therapeutically useful elastase proteins, as are pharmaceutical compositions comprising said elastase proteins. Novel recombinant elastase proteins and protein preparations are also disclosed. Methods are described for treating and preventing diseases of biological conduits using pharmaceutical compositions containing the elastase proteins of the invention.
A nucleic acid molecule encoding an autoactivating type I pancreatic proelastase protein, wherein the autoactivating type I pancreatic proelastase protein comprises an amino acid sequence which is at least 90% identical to a reference amino acid sequence consisting of SEQ ID NO:73 linked at its C-terminus to the N-terminus of SEQ ID NO:1, wherein the first thirteen amino acids of the reference amino acid sequence are P10-P9-P8-P7-P6-P5-P4-P3-P2-P1-P1′-P2′-P3′;
Dependencies are inferred from the claim text.